Cartesian Therapeutics Inc (RNAC)
25.50
+1.00
(+4.08%)
USD |
NASDAQ |
May 03, 10:52
Cartesian Therapeutics Market Cap: 453.80M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 436.00M |
| May 01, 2024 | 402.90M |
| April 30, 2024 | 392.76M |
| April 29, 2024 | 391.51M |
| April 26, 2024 | 374.25M |
| April 25, 2024 | 371.94M |
| April 24, 2024 | 368.74M |
| April 23, 2024 | 366.42M |
| April 22, 2024 | 324.96M |
| April 19, 2024 | 318.73M |
| April 18, 2024 | 307.52M |
| April 17, 2024 | 328.93M |
| April 16, 2024 | 333.73M |
| April 15, 2024 | 337.64M |
| April 12, 2024 | 344.75M |
| April 11, 2024 | 320.75M |
| April 10, 2024 | 290.17M |
| April 09, 2024 | 248.74M |
| April 08, 2024 | 233.27M |
| April 05, 2024 | 73.42M |
| April 04, 2024 | 83.42M |
| April 03, 2024 | 81.10M |
| April 02, 2024 | 87.72M |
| April 01, 2024 | 92.68M |
| March 28, 2024 | 107.56M |
| Date | Value |
|---|---|
| March 27, 2024 | 106.95M |
| March 26, 2024 | 101.09M |
| March 25, 2024 | 110.13M |
| March 22, 2024 | 115.66M |
| March 21, 2024 | 113.98M |
| March 20, 2024 | 124.59M |
| March 19, 2024 | 116.47M |
| March 18, 2024 | 102.34M |
| March 15, 2024 | 93.98M |
| March 14, 2024 | 86.69M |
| March 13, 2024 | 89.07M |
| March 12, 2024 | 95.24M |
| March 11, 2024 | 103.49M |
| March 08, 2024 | 103.65M |
| March 07, 2024 | 104.25M |
| March 06, 2024 | 113.36M |
| March 05, 2024 | 108.88M |
| March 04, 2024 | 110.13M |
| March 01, 2024 | 111.74M |
| February 29, 2024 | 118.45M |
| February 28, 2024 | 116.59M |
| February 27, 2024 | 118.09M |
| February 26, 2024 | 121.45M |
| February 23, 2024 | 118.21M |
| February 22, 2024 | 116.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
63.62M
Minimum
Nov 20 2019
567.10M
Maximum
Jun 14 2021
250.61M
Average
234.34M
Median
Market Cap Benchmarks
| Marinus Pharmaceuticals Inc | 85.69M |
| Adial Pharmaceuticals Inc | 7.056M |
| Poseida Therapeutics Inc | 280.78M |
| Viracta Therapeutics Inc | 31.46M |
| Biomea Fusion Inc | 442.55M |
Market Cap Related Metrics
| PS Ratio | 5.070 |
| Price | 25.50 |
| Earnings Yield | -195.3% |